Professional Marketing briefs

Share this article:
Sanofi-Aventis handed over Actonel marketing rights in the US to its collaborator on the drug, Warner Chilcott. Warner Chilcott will take full operational control over promotion, marketing and R&D decisions in the US and Puerto Rico. As part of the deal, Warner Chilcott will offer “a number of sales reps currently promoting Actonel for Sanofi-Aventis” jobs on the Warner Chilcott sales force.

Several female Novartis sales reps testified that doctors who crossed the professional line with their sales reps were given a free pass at Novartis. Their testimony came as part of a $200 million class-action discrimination suit against the company.

PharmaShine, an online application that launched last August, is hoping to capitalize on the difficulty of looking up publicly disclosed payments to physicians from pharmas. Users receive e-mail alerts, graphs and comparative data on payment information covering over 21,000 US physicians.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?